Cargando…
COVID-19 and diabetes cutaneous comorbidity
Diabetes patients have a higher risk in morbidity and mortality with COVID-19.It should be considered as a risk factor for a rapid progression and bad prognosis of COVID-19.Additional, the research in the cutaneous complication of diabetes with COVID-19 need to be considered. Therefore, particular c...
Autores principales: | Zhang, Minchen, Gao, Weicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445128/ https://www.ncbi.nlm.nih.gov/pubmed/32864603 http://dx.doi.org/10.1016/j.metop.2020.100055 |
Ejemplares similares
-
Update on the cutaneous manifestations of COVID-19
por: Hoenig, Leonard J.
Publicado: (2020) -
Late-onset cutaneous eruption in hospitalized COVID-19 patients
por: Brazzelli, Valeria, et al.
Publicado: (2021) -
Evolution of different clinical patterns of cutaneous lesions in a suspected COVID-19 patient
por: Quaglino, Pietro, et al.
Publicado: (2021) -
Histopathology of cutaneous COVID-19 lesion: possible SARS-CoV-2 cytopathogenic effect
por: Drak Alsibai, Kinan, et al.
Publicado: (2020) -
Pressure injury: A non-negligible comorbidity for critical Covid-19 patients
por: Yu, Nanze, et al.
Publicado: (2021)